FNY Managed Accounts’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
FNY Managed Accounts's BIIB Position: Q2 2017 in Review
FNY Managed Accounts sold out of Biogen (BIIB) in Q2 2017, closing a stake of 130 shares — an estimated $35K sold.
FNY Managed Accounts first reported a position in BIIB in Q1 2014 and held it in 3 quarters. The position peaked at $807K in Q1 2016. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.
- FNY Managed Accounts reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
- FNY Managed Accounts sold 130 Biogen shares in Q2 2017, an estimated $35K.
- FNY Managed Accounts first reported a position in Biogen in Q1 2014 and held it in 3 quarters.
- FNY Managed Accounts's Biogen position peaked at $807K in Q1 2016.
- 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.
Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.